The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...

Additional Evidence of PF614-MPAR Overdose Protection after Completion of Part 1 of Clinical Study ~ SAN DIEGO, CA / / April 15, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" ...

The National Institute for Standards and Technology’s new harm reduction initiative is helping prevent needless deaths.